Connect with us
[bsa_pro_ad_space id=12]

International

Trump’s ‘Golden Dome’ defense shield must be built now, Lt. Gen. warns

Published

4 minute read

MXM logo  MxM News

Quick Hit:

Lt. Gen. Trey Obering (Ret.), former director of the Missile Defense Agency, is calling on Congress and the Department of Defense to move quickly in support of President Donald Trump’s vision for a next-generation missile defense system—dubbed the “Golden Dome.” In a Fox News op-ed, Obering argues that a constellation of up to 2,000 satellite interceptors could defend against modern threats from China, Russia, North Korea, and Iran at a fraction of the cost of today’s ground-based systems.

Key Details:

  • The Golden Dome initiative will be presented to President Trump following his executive order mandating the development of advanced national missile defense.

  • Obering says a space-based system, enabled by AI and peer-to-peer networking, could intercept missiles earlier in their trajectory, significantly enhancing U.S. deterrence capabilities.

  • Estimated cost for the full satellite constellation would be less than the price of today’s 44 ground interceptors and global radar network.

Diving Deeper:

In a March 31 op-ed for Fox News, retired Lt. Gen. Trey Obering, who directed the Missile Defense Agency under President George W. Bush, laid out a detailed argument for why President Donald Trump’s “Golden Dome” missile defense shield is both technologically feasible and strategically necessary. “We can do this — and we must,” Obering wrote, emphasizing the urgency of the moment.

According to Obering, the current U.S. missile defense architecture—reliant on ground-based interceptors and radar systems—faces serious limitations in light of the increasingly sophisticated missile technologies being developed by U.S. adversaries. “Our existing missile-defense system cannot easily defeat some of our adversaries’ more modern, sophisticated weapons,” he noted.

The “Golden Dome” proposal envisions a network of up to 2,000 satellites in low Earth orbit, operating as both sensors and interceptors. The concept, which builds on Ronald Reagan’s Strategic Defense Initiative and the shelved “Brilliant Pebbles” program, is now achievable thanks to advances in artificial intelligence, satellite production, and space-based communications. “Each satellite has the knowledge of every other satellite,” Obering explained. “They all serve as both threat sensors and hit-to-kill interceptors.”

Obering pointed to real-world applications of this model in Ukraine, where a peer-to-peer software system—built using concepts from Uber—has helped the Ukrainian military effectively target Russian positions. A similar concept could be applied to satellite-based missile defense. “The networking concept has already proven its effectiveness on the battlefield in Ukraine,” he said.

Importantly, Obering stressed that while no missile shield is perfect, the deterrent power of such a system would be undeniable. “The capability and capacity now exists to defeat single and multiple missile launches, thereby creating strategic deterrence — or ‘peace through strength,’ in the words of both Reagan and Trump,” he wrote.

Cost is another key factor. Obering argued that this next-gen system would come in at a lower price than the 44 ground interceptors currently deployed in Alaska and California. He cited SpaceX’s Starlink, which already has over 7,000 satellites in orbit, as proof of concept for rapid and scalable deployment. “For a defense system charged with safeguarding countless lives and trillions of dollars in assets, this would be money well spent,” he said.

He also warned that bureaucratic delays must not slow the project. “We cannot allow unnecessary bureaucratic hurdles to stifle our progress,” Obering urged. He called on Congress to expedite confirmations of key defense leaders and fully fund the Golden Dome initiative, with the Missile Defense Agency as the lead coordinating body.

With China racing ahead in artificial intelligence and space defense, Obering concluded with a stark warning: “Golden Dome must be built first; the alternative is too terrible to contemplate.”

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

RFK Jr. planning new restrictions on drug advertising: report

Published on

MXM logo MxM News

Quick Hit:

The Trump administration is reportedly weighing new restrictions on pharmaceutical ads—an effort long backed by Health Secretary Robert F. Kennedy Jr. Proposals include stricter disclosure rules and ending tax breaks.

Key Details:

  • Two key proposals under review: requiring longer side-effect disclosures in TV ads and removing pharma’s tax deduction for ad spending.

  • In 2024, drug companies spent $10.8 billion on direct-to-consumer ads, with AbbVie and Pfizer among the top spenders.

  • RFK Jr. and HHS officials say the goal is to restore “rigorous oversight” over drug promotions, though no final decision has been made.

Diving Deeper:

According to a Bloomberg report, the Trump administration is advancing plans to rein in direct-to-consumer pharmaceutical advertising—a practice legal only in the U.S. and New Zealand. Rather than banning the ads outright, which could lead to lawsuits, officials are eyeing legal and financial hurdles to limit their spread. These include mandating extended disclosures of side effects and ending tax deductions for ad spending—two measures that could severely limit ad volume, especially on TV.

Health and Human Services Secretary Robert F. Kennedy Jr., who has long called for tougher restrictions on drug marketing, is closely aligned with the effort. “We are exploring ways to restore more rigorous oversight and improve the quality of information presented to American consumers,” said HHS spokesman Andrew Nixon in a written statement. Kennedy himself told Sen. Josh Hawley in May that an announcement on tax policy changes could come “within the next few weeks.”

The ad market at stake is enormous. Drugmakers spent $10.8 billion last year promoting treatments directly to consumers, per data from MediaRadar. AbbVie led the pack, shelling out $2 billion—largely to market its anti-inflammatory drugs Skyrizi and Rinvoq, which alone earned the company over $5 billion in Q1 of 2025.

AbbVie’s chief commercial officer Jeff Stewart admitted during a May conference that new restrictions could force the company to “pivot,” possibly by shifting marketing toward disease awareness campaigns or digital platforms.

Pharma’s deep roots in broadcast advertising—making up 59% of its ad spend in 2024—suggest the impact could be dramatic. That shift would mark a reversal of policy changes made in 1997, when the FDA relaxed requirements for side-effect disclosures, opening the floodgates for modern TV drug commercials.

Supporters of stricter oversight argue that U.S. drug consumption is inflated because of these ads, while critics warn of economic consequences. Jim Potter of the Coalition for Healthcare Communication noted that reinstating tougher ad rules could make broadcast placements “impractical.” Harvard professor Meredith Rosenthal agreed, adding that while ads sometimes encourage patients to seek care, they can also push costly brand-name drugs over generics.

Beyond disclosure rules, the administration is considering changes to the tax code—specifically eliminating the industry’s ability to write off advertising as a business expense. This idea was floated during talks over Trump’s original tax reform but was ultimately dropped from the final bill.

Continue Reading

International

Judiciary explores accountability options over Biden decline ‘coverup’

Published on

Former President Joe Biden salutes the departure party before boarding Special Air Mission 46 at Joint Base Andrews, Md., Jan. 20, 2025. 

From The Center Square

By

No obvious solutions emerged during a congressional hearing Wednesday on how to hold those accountable for the alleged cover-up of President Joe Biden’s mental and cognitive decline, but witnesses had some suggestions for how to prevent similar situations in the future.

Republicans have been adamant for some time that Democratic lawmakers, the prior administration, the legacy media and those closest to Biden conspired to hide the former president’s mental and cognitive decline from the American people. More recently, allegations have surfaced that some of Biden’s staff or potentially others may have used an autopen – a machine that can replicate signatures – to sign official documents for Biden without his knowledge or consent.

From the Senate Judiciary Committee hearing on June 18th, 2025

Wednesday’s witnesses agreed that further investigation needs to be done into these questions. Republicans also explored what can be done after the fact and how to prevent similar events from happening in the future. The Senate Judiciary Committee’s hearing into those questions Wednesday’s boycotted by all but one Democrat.

Republicans didn’t miss the opportunity to call them out for it. U.S. Sen. Eric Schmitt, R-MO, said Democrats’ absence and their failure to call any witnesses to testify was “deeply disappointing” but “not surprising.”

“Their absence speaks volumes – an implicit admission that the truth is too inconvenient to face,” Schmitt said. “This de facto boycott is not just a refusal to participate. It’s a refusal to serve the American people who deserve answers about who was truly leading their government.”

From the Senate Judiciary Committee hearing on June 18th, 2025

Much of the hearing’s discussion revolved around proper uses of the autopen, which witnesses testified can only be rightfully used when the president specifically delegates its use to the user. The committee also discussed Section 4 of the 25th Amendment to the Constitution, which talks about succession in the case of a president becoming unfit or unable to fulfill the role. The amendment authorizes the vice president and a majority of the president’s cabinet to declare the president unfit, though that declaration has to be validated by a vote from Congress in order to have any effect.

What’s missing, however, is a clear manner of recourse for lawmakers or the public if those around the president fail to act despite plain signs he is incapable of holding office. Republicans wanted to know what they could do to prevent the alleged conspiracy from simply fading into history without consequences for any involved.

“As a government, it is imperative that we have clear contingency plans when emergency strikes, and yes, it is an emergency when we have a sitting president who is unable to discharge the duties of that office,” said U.S. Sen. John Cornyn, R-TX.

He asked witness Theo Wold, a visiting fellow for law and technology policy with The Heritage Foundation and who worked in the previous Trump administration, if any criminal statutes could be applied to those who are found to have participated in the alleged cover-up.

“In this case, some have suggested that there may be potential crimes committed by members of the Cabinet for failing to act basically, suborning perjury, forging, forging government documents, impersonating a federal officer, making false statements, conspiracy to defraud the United States, obstruction of justice, wire or mail fraud…  Do you think there’s any application of any of those criminal statutes to the circumstances of the Biden presidency?” Cornyn asked.

“There very well could be,” Wold said, but he added that it would be “a question for a prosecutor to take up in their discretion.”

While witnesses agreed that anyone participating in a cover-up should be held accountable, the solutions for doing so weren’t as clear as recommendations for how to prevent similar situations in the future.

John Harrison, James Madison Distinguished Professor of Law at the University of Virginia, didn’t see an obvious method of redress for what already happened but suggested that Congress perhaps require greater documentation of presidential actions going forward.

Wold provided additional suggestions, such as a revival of discussion around “other guardrails” that can be imposed on the 25th Amendment. There was lively debate toward the end of Ronald Reagan’s presidency about adding a mental health professional to the White House medical team or “whether the surgeon general should oversee the inclusion of medical reporting as part of… the 25th Amendment,” according to Wold. But he said there hadn’t been serious discussion since on how to improve the amendment. He also agreed with Sen. Katie Britt, R-AL, that some of the terms in the amendment, like “unable,” should be more clearly defined.

Continue Reading

Trending

X